Author: Abhay Panchal

Fifty pediatric centers were ranked in treating digestive disorders in children. Liver transplant survival and treatment of inflammatory bowel issues, patient volume, commitment to best practices, advanced clinical staff and technologies and prevention of ICU infections, along with other data collected from a detailed U.S. News clinical survey of children’s hospitals accounted for most of each hospital’s score.

Read More

Digestive and Liver Health Specialists, a premier gastroenterology practice, is excited to announce its expansion, providing even greater access to high-quality healthcare services for patients in Middle Tennessee. With four existing locations in Clarksville, Hendersonville, Nashville, and Smyrna, the practice is proud to introduce its fifth city, Murfreesboro, TN, as the newest addition to its growing network. Appointments at the Murfreesboro location will be available starting in late summer 2023.

Read More

Physicians at the American Medical Association (AMA) annual House of Delegates meeting advocated for the AMA to take a more active role in addressing healthcare consolidation. They pushed for the production of comprehensive annual reports on the topic, which could be used to support legislative changes. The request came from the AMA’s Private Practice Physicians Section, who argued that healthcare consolidation has negative consequences for physicians. They believe that consolidation limits physicians’ autonomy, imposes restrictions on their practice, and contributes to increased burnout.

Read More

The article discusses a partnership between Ayble, a healthcare technology company, and FrontRow, a healthcare platform, to enhance gut health for healthcare providers and patients. The collaboration aims to provide better access to tools and resources related to gut health. Ayble specializes in personalized gut health solutions, while FrontRow is a platform that connects healthcare providers with innovative healthcare technologies. Through this partnership, Ayble’s gut health solutions will be integrated into FrontRow’s platform, making them accessible to thousands of healthcare providers and patients.

Read More

The article discusses recent research indicating that changes in the gut microbiome may offer a potential method for detecting Alzheimer’s disease (AD) at an early stage, even before the appearance of noticeable symptoms. Detecting AD in its early phases is crucial for effective treatment. The study, published in Science Translational Medicine, focused on individuals in the initial stages of AD who showed no signs of cognitive decline. The researchers discovered that these individuals had a distinct composition of gut microbes compared to healthy individuals.

Read More

The SmartPill, a wireless ingestible capsule containing sensors that monitor pressure, pH, transit time and temperature as it passes through the gastrointestinal tract, is being discontinued, a spokesperson for its manufacturer, Medtronic, confirmed on June 21.The company did not say when or why the product was being discontinued, but experts said it was almost certainly related to a business decision, not a safety issue. Braden Kuo, MD, of Massachusetts General Hospital, Boston, a motility specialist who took part in the SmartPill’s development and testing at various stages, said that Medtronic’s decision to discontinue the device was already known among his…

Read More

CHICAGO—Underwater endoscopic mucosal resection has numerous advantages over the conventional approach for the resection of colorectal polyps, according to a meta-analysis presented at Digestive Disease Week 2023. “We found that for all lesions, irrespective of their size, underwater endoscopic mucosal resection [U-EMR] outperforms conventional EMR [C-EMR] in terms of en bloc resection, R0 resection and rate of polyp recurrence,” said Saurabh Chandan, MD, an assistant professor of gastroenterology at Creighton University School of Medicine, in Omaha, Neb. However, the data are less clear for lesions larger than 20 mm, he added. “I would say that U-EMR is comparable to C-EMR,…

Read More

The article discusses the effectiveness of the next-generation Cologuard test in non-invasive screening for colorectal cancer. According to the findings, the test demonstrated a sensitivity of 94% for detecting colorectal cancer with a specificity of 91%. Sensitivity refers to the test’s ability to correctly identify individuals who have colorectal cancer, while specificity refers to its ability to correctly identify individuals who do not have the disease.

Read More